Maana WellnessDoes ESWT Work for Trigger Points? Here’s What the Research Shows
Written by Shilpa Sunny. Reviewed for clinical accuracy by Jasmal K.
Extracorporeal shockwave therapy (ESWT) has a more consistent evidence base for myofascial pain than many other physical therapies — multiple independent meta-analyses point the same direction. Here’s what the research actually shows, including its real limits.
The Short Version
Several independent systematic reviews and meta-analyses, conducted by different research teams in different years, have found that ESWT reduces pain and improves function in myofascial pain syndrome (the clinical term for trigger point-related pain). This is a more consistent, more repeated finding across the literature than what exists for many competing treatments. The honest caveat: ESWT has been shown to clearly beat inactive treatment (sham ESWT, ultrasound) — but the evidence that it beats other active treatments like dry needling or trigger point injections is weaker and less consistent.
What the Meta-Analyses Show
A 2022 systematic review and meta-analysis (published in Annals of Translational Medicine) pooled 8 controlled clinical studies covering 571 patients with myofascial pain syndrome. It found ESWT reduced pain, increased pain threshold, and reduced shoulder and neck disability scores compared with other treatment methods.
A 2020 systematic review and meta-analysis (ScienceDirect) focused specifically on myofascial pain syndrome of the trapezius muscle, covering 10 studies and 477 patients. It found a clear, statistically significant pain reduction for ESWT compared with sham ESWT or ultrasound treatment. Importantly, when compared directly against conventional active treatments — dry needling, trigger point injection, and similar approaches — the improvement was not statistically significant. In plain terms: ESWT reliably beats doing nothing (or a fake treatment), but the evidence doesn’t clearly show it beats other real treatment options.
A separate 2019 systematic review and meta-analysis, also focused on trapezius myofascial pain syndrome, reviewed 5 randomized controlled trials specifically measuring ESWT’s short-term effect on pain intensity, adding further independent support to the pain-reduction finding.
A 2025 scoping review (published via PMC, searching through August 2025) took a more critical look at the field as a whole, evaluating mechanisms, applications, and methodological consistency across ESWT-for-myofascial-pain research. It identified real inconsistencies in how myofascial pain syndrome and trigger points are diagnosed, how shockwave protocols are applied, and how long studies follow up patients — and made a specific, honest point worth repeating: because no examination technique for myofascial trigger points currently provides fully reliable, reproducible diagnostic data, all research in this area — including the positive findings above — sits on somewhat unstable diagnostic ground.
The Honest Limitations
- ESWT beats placebo, but not clearly better than alternatives. The clearest, most repeated finding is that ESWT outperforms sham treatment — evidence that it’s superior to manual techniques like dry needling or trigger point injection is weaker.
- Diagnostic inconsistency undercuts the whole field. Since there’s no universally reliable way to diagnose a “trigger point” in the first place, every study — including the positive ones — is working from a somewhat inconsistent starting definition.
- Protocol variation. Shockwave intensity, session count, and technique vary across studies, similar to the device-variation issue seen in spinal decompression research.
- Most trials focus on the trapezius/neck-shoulder region. Much of the strongest evidence is specifically about upper back and neck myofascial pain — evidence for other muscle groups is comparatively thinner.
The Bottom Line
Of the modalities we’ve reviewed so far, ESWT for myofascial trigger points has one of the more consistent evidence bases — multiple independent meta-analyses, run by different teams, converge on the same core finding: real pain reduction versus placebo. The fair caveat is that this doesn’t mean ESWT is proven superior to manual trigger-point release techniques — the honest position is that they’re different, both reasonably evidenced approaches, not that one is definitively better than the other.
References
- Efficacy of Extracorporeal Shockwave Therapy on Pain and Function in Myofascial Pain Syndrome of the Trapezius: A Systematic Review and Meta-Analysis. ScienceDirect, 2020. sciencedirect.com/science/article/abs/pii/S0003999320301556
- Efficacy of extracorporeal shock waves in the treatment of myofascial pain syndrome: a systematic review and meta-analysis of controlled clinical studies. Wu et al., Annals of Translational Medicine, 2022. atm.amegroups.org/article/view/90044/html
- The effect of focused extracorporeal shock wave therapy on myofascial pain syndrome of trapezius. Systematic review and meta-analysis, 2019. doi.org/10.1097/MD.0000000000019085
- The State of Extracorporeal Shockwave Therapy for Myofascial Pain Syndrome — A Scoping Review and a Call for Standardized Protocols. PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12565389